IN THE NEWS
	On Feb. 27, the NCI announced that it has allotted roughly $20 million over five years to fund a Center of Cancer Nanotechnology Excellence at the School of Medicine.

As world-class experts from the Schools of Medicine, Engineering and Humanities & Sciences, program members collaborate between disciplines to develop powerful, new tools for tracking and analyzing the cellular, molecular and genetic processes of cancer as they occur in patients and animal models.

By expanding the reach of researchers and clinicians, these tools are leading to new insights into the underlying principles of cancer etiology and progression, as well as better patient outcomes through earlier diagnosis and more effective treatment delivery.

Among the program’s many breakthroughs are new methods for imaging cancer gene therapy, cell trafficking and apoptosis, novel instrumentation for imaging breast cancer and new interactive, 3-D models for the combined analysis of a patient’s biochemical and anatomical data.

	Building on a long-standing tradition of innovation across Stanford University, the program leverages member expertise in: • imaging instrumentation/ engineering • modeling/biostatistics • chemistry • molecular imaging assay development • cancer biology/proteomics • mouse models/small animal imaging • clinical oncology

Current efforts focus on:

Imaging Instrumentation

Multimodal Imaging Strategies

Methods for Studying Cancer Biology & Treatment Efficacy

Nanotechnology Diagnostics

Management of Cancer Imaging Knowledge

For more information, visit the Molecular Imaging Program
at Stanford website: (http://mips.stanford.edu)

Program Directors

Sanjiv Gambhir, MD, PhD

Christopher Contag, PhD